Clinical trial
Lenalidomide and Low Dose Dexamethasone Versus Bortezomib, Lenalidomide and Low Dose Dexamethasone for Induction, in Patients With Previously Untreated Multiple Myeloma
NCT01530594 is registered in ClinicalTrials.gov with King Faisal Specialist Hospital & Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lenalidomide and Low Dose Dexamethasone Versus Bortezomib, Lenalidomide and Low Dose Dexamethasone for Induction, in Patients With Previously Untreated Multiple Myeloma
- Lead sponsor
- King Faisal Specialist Hospital & Research Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- January 31, 2013
- Enrollment
- 440 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.